More screening to cut EU cancer deaths, says Italy:
This article was originally published in Clinica
Executive Summary
More screening is needed to further reduce cancer mortality, says the Italian health ministry in response to a study published recently on the evolution of cancer care across the EU. Some 92,750 cancer-related deaths were averted across the EU, between 1985-2000, 9% less than had been estimated. The target set in 1985 was to cut cancer mortality in 2000 by 15%. Italy - together with Luxembourg and the UK - fell short, with a 13% reduction. Austria and Finland met the target, while Portugal and Greece performed worst. "Screening, particularly of women, with Pap cervical smear testing and mammography, are key to further reducing cancer mortality," says the Italian health ministry.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.